← Back to the feed
Forecast2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.

SHIN Nippon Biomedical FY2027/3 Q2 Earnings Forecast Upward Revision

– SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) has revised its FY2027/3 Q2 consolidated earnings forecast. FORECAST REVISION SUMMARY: (Unit: millions of yen) Revenue Op Profit Ord Profit Net Profit Previous Forecast (A) 16,596 463 1,948 1,167 Revised Forecast (B) 17,154 1,240 2,988 1,917 Prior Year Actual 14,766 49 1,627 1,061 KEY CHANGES: - Net profit forecast raised to 1,917 - Operating profit forecast raised to 1,240

Forecast revision — FY2027/3Upward revision

MetricPriorRevisedChange
Revenue¥16,596M¥17,154M+3.4%
Op. profit¥463M¥1,240M+167.8%
Net profit¥1,167M¥1,917M+64.3%

Figures in millions of yen

PDFOriginal disclosure11:30 JSTView original ↗
End of article